Navigation Links
ResMed's New Nasal Pillows System is Our Quietest Yet; Ultra-light AirFit P10 Packs Powerful Performance in Just over 1.5 Ounces

SAN DIEGO, Jan. 13, 2014 /PRNewswire/ -- ResMed (NYSE: RMD) continues its 25-year history of innovating powerful and comfortable solutions for treating sleep-disordered breathing with today's introduction of the ultra-light, ultra-quiet ResMed AirFit™ P10 nasal pillows system.




The AirFit P10 weighs just 1.6 ounces, and has only three parts, including a new soft and stable QuickFit™ headgear. ResMed has pioneered a new mesh vent called QuietAir™ so the AirFit P10 is 50 percent quieter than its predecessor, diffusing air with minimal disturbance to patients or their bed partners. ResMed's AirFit P10 maintains a secure seal while delivering a high level of facial freedom.

"The AirFit P10's light weight and ultra-quiet performance also translates directly into better compliance," said Jon Yerbury, vice president of ResMed's Sleep-Disordered Breathing Strategic Business Unit. "Our internal research has shown that the AirFit P10 provides an average of 40 more minutes of sleep per night than ResMed's current market-leading nasal pillows mask."

For the convenience of ResMed's home medical equipment provider customers as well as patients, the AirFit P10 has color-coded cushion sizing, with small, medium and large sizes in the standard AirFit P10 system, and extra-small, small and medium sizes in the AirFit For Her system, which features headgear designed for women.

ResMed's AirFit P10 begins shipping in the U.S. today.

About ResMed: ResMed is a global leader in the development, manufacturing and marketing of medical products for the diagnosis, treatment and management of respiratory disorders, with a focus on sleep-disordered breathing. The company is dedicated to developing innovative products to improve the lives of those who suffer from these conditions and to increasing awareness among patients and healthcare professionals of the potentially serious health consequences of untreated sleep-disordered breathing. For more information on ResMed, visit Contacts:For News MediaFor InvestorsGretchen Griswold

David PendarvisDirector, Global Corporate Communications

Chief Administrative Officer and GlobalO: 858-836-6789



SOURCE ResMed Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Initial Data from Lightlake Therapeutics Joint Clinical Trial with NIDA Shows Nasal Delivery of Naloxone for Opioid Overdose as a Promising Treatment
2. Systematic Review Finds Intranasal Midazolam Comparable To Intravenous Or Rectal Administration Of Diazepam For Treatment Of Acute Seizure Emergencies In Pediatric Patients
3. ResMeds New Nasal Mask Sets the Bar for Comfort and Performance
4. Considering Corticosteroid Nasal Sprays
5. North American Drug Delivery Technologies Market (Metered Dose Inhalers, Needle-Free Injectors, Auto-Injectors, Nasal Sprays, Transdermal Patches, Nebulizers, Infusion Pumps, Drug Eluting Stents, Sustained Release, Ocular Implants) - Forecasts To 20
6. Upsher-Smith Announces Patient Enrollment In Open-label Safety Study Of USL261 (Intranasal Midazolam) For Rescue Treatment Of Seizure Clusters In Epilepsy
7. Aegis Awarded 2nd Patent for Fast Acting Migraine Nasal Spray Treatment
8. Besins Healthcare, Shin Nippon Biomedical Laboratories, Ltd Announce Delivery Technology Licensing Agreement for Intranasal Progesterone
9. Emerging Data on USL261 (Intranasal Midazolam) to Be Presented at the 66th Annual Meeting of the American Epilepsy Society
10. Sleep Apnea Diagnostic & Therapeutic Devices Market [Polysomnographs, Respiratory Polygraphs, Pulse Oximeters, CPAP, Masks, Adaptive Servo-Ventilation (ASV), Oral Appliances, Nasal EPAP, Neurostimulation] Global End-user Analysis, Competitive Landsc
11. US Intranasal Drug Delivery Industry
Post Your Comments:
(Date:11/30/2015)... -- MEDTEC Japan 2016, Asia,s largest exhibition and conference ... in Tokyo from 20 th  - 22 nd April 2016. ...   --> -->   ... . With the aging population and the government back up, the Medical ... the United States . With the aging population and the ...
(Date:11/30/2015)... , Nov. 30, 2015 Nevro Corp. (NYSE: ... innovative evidence-based solutions for the treatment of chronic pain, today ... the U.S. Patent and Trademark Office (USPTO) has denied instituting ... No. 8,359,102 (the ,102 patent).  --> ... of Boston Scientific Corporation filed two petitions challenging the validity ...
(Date:11/30/2015)... ) has ... Market 2015-2019" report to their offering. ... of the "Orphan Drugs Market 2015-2019" ... and Markets ( ) has announced the ... report to their offering. ...
Breaking Medicine Technology:
(Date:11/30/2015)... MN (PRWEB) , ... November 30, 2015 , ... ... at . The directory is specialized and only includes chiropractic clinics ... to find a competent and trustworthy alternative health practitioner when back pain sets ...
(Date:11/30/2015)... ... November 30, 2015 , ... The Museum ... summer, ushering in a new era of publicly accessible automated technology. Now, by ... continue to offer guests an up-close look at the shuttle at MOSI’s main ...
(Date:11/30/2015)... ... November 30, 2015 , ... In an effort to provide ... of Life Christian Church of Flint, MI, hosted a family-oriented evening themed on ... pile of candy dubbed “Candy Mountain”. , A Forever Recovery, a holistic treatment ...
(Date:11/30/2015)... ... November 30, 2015 , ... In an ... States to access life-saving information provided directly from top experts in mesothelioma, ... three individual conferences in three major cities: Houston, San Francisco, and Chicago. ...
(Date:11/30/2015)... ... 2015 , ... During the week of Thanksgiving, the Mesothelioma ... its research, education, support, and advocacy efforts. The campaign is held every year-end ... Applied Research Foundation, which also goes by Meso Foundation, holds the highest ...
Breaking Medicine News(10 mins):